Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Assets Average (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Assets Average over the past 15 years, most recently at $238.5 million for Q2 2025.

  • For Q2 2025, Assets Average fell 4.63% year-over-year to $238.5 million; the TTM value through May 2025 reached $238.5 million, down 4.63%, while the annual FY2025 figure was $246.7 million, 2.8% down from the prior year.
  • Assets Average for Q2 2025 was $238.5 million at Lifecore Biomedical, Inc. \De\, down from $246.5 million in the prior quarter.
  • Over five years, Assets Average peaked at $504.4 million in Q2 2021 and troughed at $238.5 million in Q2 2025.
  • A 5-year average of $311.5 million and a median of $253.7 million in 2023 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: grew 19.58% in 2021 and later crashed 42.84% in 2022.
  • Year by year, Assets Average stood at $433.0 million in 2021, then crashed by 37.38% to $271.2 million in 2022, then fell by 9.39% to $245.7 million in 2023, then rose by 2.19% to $251.1 million in 2024, then decreased by 5.01% to $238.5 million in 2025.
  • Business Quant data shows Assets Average for LFCR at $238.5 million in Q2 2025, $246.5 million in Q1 2025, and $251.1 million in Q4 2024.